These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29668951)

  • 1. Comparable Serologic Responses to 2 Different Combinations of Inactivated Hepatitis A Virus Vaccines in HIV-Positive Patients During an Acute Hepatitis A Outbreak in Taiwan.
    Lin KY; Hsieh SM; Sheng WH; Lo YC; Chuang YC; Cheng A; Pan SC; Chen GJ; Sun HY; Hung CC; Chang SC
    J Infect Dis; 2018 Jul; 218(5):734-738. PubMed ID: 29668951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of immunogenicity of two hepatitis A vaccines--VAQTA and HAVRIX--in young adults.
    Ashur Y; Adler R; Rowe M; Shouval D
    Vaccine; 1999 May; 17(18):2290-6. PubMed ID: 10403597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, cross-over, controlled comparison of two inactivated hepatitis A vaccines.
    Bryan JP; Henry CH; Hoffman AG; South-Paul JE; Smith JA; Cruess D; Spieker JM; de Medina M
    Vaccine; 2000 Nov; 19(7-8):743-50. PubMed ID: 11115695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, double-blind study in healthy adults to assess the boosting effect of Vaqta or Havrix after a single dose of Havrix.
    Connor BA; Phair J; Sack D; McEniry D; Hornick R; Banerjee D; Jensen E; Kuter B
    Clin Infect Dis; 2001 Feb; 32(3):396-401. PubMed ID: 11170947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children.
    Abarca K; Ibánez I; Perret C; Vial P; Zinsou JA
    Int J Infect Dis; 2008 May; 12(3):270-7. PubMed ID: 17988917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serologic responses and effectiveness of hepatitis A vaccination among human immunodeficiency virus-positive individuals during the outbreak of acute hepatitis A.
    Lin KY; Hsieh SM; Sun HY; Lo YC; Sheng WH; Chuang YC; Cheng A; Pan SC; Chen GJ; Hung CC; Chang SC
    Hepatology; 2018 Jul; 68(1):22-31. PubMed ID: 29328508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interchangeability and tolerability of two inactivated hepatitis A vaccines in Chinese children.
    Zhang ZL; Zhu XJ; Wang X; Liang M; Sun J; Liu Y; Gao ZG; Wu JY; Dong XJ; Liu RK; Chen JT; Zhang YQ; Wang W; Zhang LP; Yin W
    Vaccine; 2012 Jun; 30(27):4028-33. PubMed ID: 22537990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised comparison of two inactivated hepatitis A vaccines, Avaxim and Vaqta, given as a booster to subjects primed with Avaxim.
    Clarke P; Kitchin N; Souverbie F
    Vaccine; 2001 Aug; 19(31):4429-33. PubMed ID: 11483268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Durability of serologic responses to inactivated hepatitis A virus vaccination among people living with HIV following acute hepatitis A outbreak: a 5-year follow-up study.
    Lin KY; Sun HY; Huang YS; Liu WD; Hsieh SM; Huang SH; Chen GJ; Hung CC
    Emerg Microbes Infect; 2023 Dec; 12(2):2239946. PubMed ID: 37470725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interchangeability of a hepatitis A vaccine second dose: Avaxim 80 following a first dose of Vaqta 25 or Havrix 720 in children in Turkey.
    Soysal A; Gokçe I; Pehlivan T; Bakir M
    Eur J Pediatr; 2007 Jun; 166(6):533-9. PubMed ID: 17318620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative immunogenicity and tolerance of Vaqta and Havrix.
    Braconier JH; Wennerholm S; Norrby SR
    Vaccine; 1999 Apr; 17(17):2181-4. PubMed ID: 10367952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review.
    Lin KY; Chen GJ; Lee YL; Huang YC; Cheng A; Sun HY; Chang SY; Liu CE; Hung CC
    World J Gastroenterol; 2017 May; 23(20):3589-3606. PubMed ID: 28611512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of immunogenicity and persistence between inactivated hepatitis A vaccine Healive® and Havrix® among children: A 5-year follow-up study.
    Yu C; Song Y; Qi Y; Li C; Jiang Z; Li C; Zhang W; Wang L; Xia J
    Hum Vaccin Immunother; 2016 Oct; 12(10):2595-2602. PubMed ID: 27385349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of aluminum-adsorbed hepatitis A vaccine (Havrix®) administered as a third dose after primary doses of Japanese aluminum-free hepatitis A vaccine (Aimmugen®) for Japanese travelers to endemic countries.
    Fukushima S; Kiyohara T; Ishii K; Nakano T; Hamada A
    Vaccine; 2017 Nov; 35(47):6412-6415. PubMed ID: 29029942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of acute hepatitis A among HIV-positive patients during an outbreak among MSM in Taiwan: Impact of HAV vaccination.
    Chen GJ; Lin KY; Sun HY; Sheng WH; Hsieh SM; Huang YC; Cheng A; Liu WC; Hung CC; Chang SC
    Liver Int; 2018 Apr; 38(4):594-601. PubMed ID: 28482131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis A vaccine response in HIV-infected patients: are TWINRIX and HAVRIX interchangeable?
    Jimenez HR; Hallit RR; Debari VA; Slim J
    Vaccine; 2013 Feb; 31(9):1328-33. PubMed ID: 23277097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological responses to revaccination with hepatitis A virus (HAV) vaccines among HIV-positive individuals whose anti-HAV antibody waned after primary vaccination.
    Chen GJ; Sun HY; Lin KY; Cheng A; Huang YC; Hsieh SM; Sheng WH; Liu WC; Hung CC; Chang SC
    Liver Int; 2018 Jul; 38(7):1198-1205. PubMed ID: 29240985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low immune response rate of HIV-infected patients to a single injection of hepatitis A vaccine.
    Noël L; Tubiana R; Simon A; Valantin MA; Palich R; Blanc C; Katlama C; Marcelin AG; Calvez V; Todesco E
    Infect Dis Now; 2021 Feb; 51(1):94-96. PubMed ID: 33022294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Seroreversion After 2 Doses of Hepatitis A Vaccination in Human Immunodeficiency Virus-Positive Patients: Incidence and Associated Factors.
    Huang SH; Huang CH; Wang NC; Chen TC; Lee YT; Lin SP; Lin TY; Lin CY; Lee YL; Lee CH; Chen CP; Lin KY; Chen GJ; Liu CE; Cheng SH; Lu PL; Yang CJ; Hung CC;
    Hepatology; 2019 Aug; 70(2):465-475. PubMed ID: 30614542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excellent booster response 4 to 8 years after a single primary dose of an inactivated hepatitis A vaccine.
    Iwarson S; Lindh M; Widerström L
    J Travel Med; 2004; 11(2):120-1. PubMed ID: 15109480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.